IIL - Intravenous Infusions Limited
Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||0|
|Growth & Valuation|
|Earnings Per Share||0.0138|
|Dividend Per Share||0.0029|
IIL Stock Market Performance
The current share price of Intravenous Infusions Limited (IIL) is GHS 0.05. IIL closed its last trading day (Friday, September 3, 2021) at 0.05 GHS per share on the Ghana Stock Exchange (GSE).
Intravenous Infusions is the 12th most traded stock on the Ghana Stock Exchange over the past three months (Jun 25 - Sep 24, 2021). IIL has traded a total volume of 252,300 shares valued at GHS 12,615 over the period, with an average of 4,005 traded shares per session. A volume high of 100,000 was achieved on July 1st for the same period. The table below details the last 10 trading days of activity of Intravenous Infusions on the Ghana Stock Exchange.
Profile of Intravenous Infusions Limited
Intravenous Infusions Limited operates in the Health Care sector.
|Factsheet of Intravenous Infusions Limited|
Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
IIL Industrial Market Competitors
Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have one market competitor who is also engaged in the Health Care sector. The table below presents an overview of their market standing.